Global AI Medicine Software
Global AI Medicine Software

AI Medicine Software Comprehensive Study by Application (Diagnosis Processes, Treatment Protocol Development, Drug Development, Personalized Medicine, Patient Monitoring & Care), Enterprise Size (Small and Medium Enterprises, Large Enterprises), Deployment (Cloud, On-Premises), End-user (Hospitals, Diagnostic Centers, Laboratories, Research Institutions, Others) Players and Region - Global Market Outlook to 2027

AI Medicine Software Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Jan 2022 Edition 214 Pages 72 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is AI Medicine Software?
AI is commonly used in medical science for the diagnosis process, end-to-end drug discovery and development, remote patient monitoring, transcribing medical documents, etc. The new technology AI and machine learning play a vital role in end-to-end drug development as it requires reading a huge amount of data from various sources including research papers, patient records, images, genes, symptoms, diseases, proteins, tissues, and many more. The healthcare facilities are also focusing on improving patient care by reducing medical errors and personalized medicines, which is expected to accelerate the market growth in the nearer future.

The market study is broken down, by Application (Diagnosis Processes, Treatment Protocol Development, Drug Development, Personalized Medicine and Patient Monitoring & Care) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global AI Medicine Software market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

IBM (United States), Oncora Medical (United States), Babylon Health (United Kingdom), Arterys (United States), CloudMedx (United States), Corti (Denmark), Sophia Genetics (Switzerland), Enlitic (United States), Caption Health (United States), 3M (United States), OSP (United States), Microsoft Corporation (United States), GNS Healthcare (United States), Carta Healthcare (United States), Ada Health (Germany), Sirona Medical (United States) and Promaton (Netherlands) are some of the key players that are part of study coverage.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global AI Medicine Software market by Type, Application and Region.

On the basis of geography, the market of AI Medicine Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Enterprise Size, the sub-segment i.e. Small and Medium Enterprises will boost the AI Medicine Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Deployment, the sub-segment i.e. Cloud will boost the AI Medicine Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-user, the sub-segment i.e. Hospitals will boost the AI Medicine Software market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.




Market Trend
  • Integration of NLP Enabled Chatbot Technologies with the AI systems to create a Virtual Interventional Radiologist (VIR)

Market Drivers
  • Surging Demand for Advanced Technologies to Eliminate Medical Errors and Improve Quality of Patient Care
  • Increasing Use of AI and Machine Learning for the New Drug Development and Increase Efficiency of Diagnosis Processes

Opportunities
  • The Standardization of Hospital Administration to Improve Management Decisions and Remote Monitoring of Patients

Restraints
  • Possibility of Inaccuracy and Rising Security Concerns Due to Increasing Number of Cyberattacks in the Healthcare Sector

Challenges
  • High Cost of Software and Requirement of Extensively Trained Staff


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, AI Medicine Software Providers, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, End-Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as IBM (United States), Oncora Medical (United States), Babylon Health (United Kingdom), Arterys (United States), CloudMedx (United States), Corti (Denmark), Sophia Genetics (Switzerland), Enlitic (United States), Caption Health (United States), 3M (United States), OSP (United States), Microsoft Corporation (United States), GNS Healthcare (United States), Carta Healthcare (United States), Ada Health (Germany), Sirona Medical (United States) and Promaton (Netherlands) etc.

2. Can we have customized study for AI Medicine Software Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of AI Medicine Software Market by 2027?
Analysts at AMA estimates AI Medicine Software Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By Application
  • Diagnosis Processes
  • Treatment Protocol Development
  • Drug Development
  • Personalized Medicine
  • Patient Monitoring & Care
By Enterprise Size
  • Small and Medium Enterprises
  • Large Enterprises

By Deployment
  • Cloud
  • On-Premises

By End-user
  • Hospitals
  • Diagnostic Centers
  • Laboratories
  • Research Institutions
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Surging Demand for Advanced Technologies to Eliminate Medical Errors and Improve Quality of Patient Care
      • 3.2.2. Increasing Use of AI and Machine Learning for the New Drug Development and Increase Efficiency of Diagnosis Processes
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Software and Requirement of Extensively Trained Staff
    • 3.4. Market Trends
      • 3.4.1. Integration of NLP Enabled Chatbot Technologies with the AI systems to create a Virtual Interventional Radiologist (VIR)
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global AI Medicine Software, by Application, Enterprise Size, Deployment, End-user and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global AI Medicine Software (Value)
      • 5.2.1. Global AI Medicine Software by: Application (Value)
        • 5.2.1.1. Diagnosis Processes
        • 5.2.1.2. Treatment Protocol Development
        • 5.2.1.3. Drug Development
        • 5.2.1.4. Personalized Medicine
        • 5.2.1.5. Patient Monitoring & Care
      • 5.2.2. Global AI Medicine Software by: Enterprise Size (Value)
        • 5.2.2.1. Small and Medium Enterprises
        • 5.2.2.2. Large Enterprises
      • 5.2.3. Global AI Medicine Software by: Deployment (Value)
        • 5.2.3.1. Cloud
        • 5.2.3.2. On-Premises
      • 5.2.4. Global AI Medicine Software by: End-user (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Centers
        • 5.2.4.3. Laboratories
        • 5.2.4.4. Research Institutions
        • 5.2.4.5. Others
      • 5.2.5. Global AI Medicine Software Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. AI Medicine Software: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IBM (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Oncora Medical (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Babylon Health (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arterys (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. CloudMedx (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Corti (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sophia Genetics (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Enlitic (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Caption Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. 3M (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. OSP (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Microsoft Corporation (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. GNS Healthcare (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Carta Healthcare (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Ada Health (Germany)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Sirona Medical (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Promaton (Netherlands)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
  • 7. Global AI Medicine Software Sale, by Application, Enterprise Size, Deployment, End-user and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global AI Medicine Software (Value)
      • 7.2.1. Global AI Medicine Software by: Application (Value)
        • 7.2.1.1. Diagnosis Processes
        • 7.2.1.2. Treatment Protocol Development
        • 7.2.1.3. Drug Development
        • 7.2.1.4. Personalized Medicine
        • 7.2.1.5. Patient Monitoring & Care
      • 7.2.2. Global AI Medicine Software by: Enterprise Size (Value)
        • 7.2.2.1. Small and Medium Enterprises
        • 7.2.2.2. Large Enterprises
      • 7.2.3. Global AI Medicine Software by: Deployment (Value)
        • 7.2.3.1. Cloud
        • 7.2.3.2. On-Premises
      • 7.2.4. Global AI Medicine Software by: End-user (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Centers
        • 7.2.4.3. Laboratories
        • 7.2.4.4. Research Institutions
        • 7.2.4.5. Others
      • 7.2.5. Global AI Medicine Software Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. AI Medicine Software: by Application(USD Million)
  • Table 2. AI Medicine Software Diagnosis Processes , by Region USD Million (2016-2021)
  • Table 3. AI Medicine Software Treatment Protocol Development , by Region USD Million (2016-2021)
  • Table 4. AI Medicine Software Drug Development , by Region USD Million (2016-2021)
  • Table 5. AI Medicine Software Personalized Medicine , by Region USD Million (2016-2021)
  • Table 6. AI Medicine Software Patient Monitoring & Care , by Region USD Million (2016-2021)
  • Table 7. AI Medicine Software: by Enterprise Size(USD Million)
  • Table 8. AI Medicine Software Small and Medium Enterprises , by Region USD Million (2016-2021)
  • Table 9. AI Medicine Software Large Enterprises , by Region USD Million (2016-2021)
  • Table 10. AI Medicine Software: by Deployment(USD Million)
  • Table 11. AI Medicine Software Cloud , by Region USD Million (2016-2021)
  • Table 12. AI Medicine Software On-Premises , by Region USD Million (2016-2021)
  • Table 13. AI Medicine Software: by End-user(USD Million)
  • Table 14. AI Medicine Software Hospitals , by Region USD Million (2016-2021)
  • Table 15. AI Medicine Software Diagnostic Centers , by Region USD Million (2016-2021)
  • Table 16. AI Medicine Software Laboratories , by Region USD Million (2016-2021)
  • Table 17. AI Medicine Software Research Institutions , by Region USD Million (2016-2021)
  • Table 18. AI Medicine Software Others , by Region USD Million (2016-2021)
  • Table 19. South America AI Medicine Software, by Country USD Million (2016-2021)
  • Table 20. South America AI Medicine Software, by Application USD Million (2016-2021)
  • Table 21. South America AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 22. South America AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 23. South America AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 24. Brazil AI Medicine Software, by Application USD Million (2016-2021)
  • Table 25. Brazil AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 26. Brazil AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 27. Brazil AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 28. Argentina AI Medicine Software, by Application USD Million (2016-2021)
  • Table 29. Argentina AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 30. Argentina AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 31. Argentina AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 32. Rest of South America AI Medicine Software, by Application USD Million (2016-2021)
  • Table 33. Rest of South America AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 34. Rest of South America AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 35. Rest of South America AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 36. Asia Pacific AI Medicine Software, by Country USD Million (2016-2021)
  • Table 37. Asia Pacific AI Medicine Software, by Application USD Million (2016-2021)
  • Table 38. Asia Pacific AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 39. Asia Pacific AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 40. Asia Pacific AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 41. China AI Medicine Software, by Application USD Million (2016-2021)
  • Table 42. China AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 43. China AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 44. China AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 45. Japan AI Medicine Software, by Application USD Million (2016-2021)
  • Table 46. Japan AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 47. Japan AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 48. Japan AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 49. India AI Medicine Software, by Application USD Million (2016-2021)
  • Table 50. India AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 51. India AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 52. India AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 53. South Korea AI Medicine Software, by Application USD Million (2016-2021)
  • Table 54. South Korea AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 55. South Korea AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 56. South Korea AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 57. Australia AI Medicine Software, by Application USD Million (2016-2021)
  • Table 58. Australia AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 59. Australia AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 60. Australia AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 61. Rest of Asia-Pacific AI Medicine Software, by Application USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 65. Europe AI Medicine Software, by Country USD Million (2016-2021)
  • Table 66. Europe AI Medicine Software, by Application USD Million (2016-2021)
  • Table 67. Europe AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 68. Europe AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 69. Europe AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 70. Germany AI Medicine Software, by Application USD Million (2016-2021)
  • Table 71. Germany AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 72. Germany AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 73. Germany AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 74. France AI Medicine Software, by Application USD Million (2016-2021)
  • Table 75. France AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 76. France AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 77. France AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 78. Italy AI Medicine Software, by Application USD Million (2016-2021)
  • Table 79. Italy AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 80. Italy AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 81. Italy AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 82. United Kingdom AI Medicine Software, by Application USD Million (2016-2021)
  • Table 83. United Kingdom AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 84. United Kingdom AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 85. United Kingdom AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 86. Netherlands AI Medicine Software, by Application USD Million (2016-2021)
  • Table 87. Netherlands AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 88. Netherlands AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 89. Netherlands AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 90. Rest of Europe AI Medicine Software, by Application USD Million (2016-2021)
  • Table 91. Rest of Europe AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 92. Rest of Europe AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 93. Rest of Europe AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 94. MEA AI Medicine Software, by Country USD Million (2016-2021)
  • Table 95. MEA AI Medicine Software, by Application USD Million (2016-2021)
  • Table 96. MEA AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 97. MEA AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 98. MEA AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 99. Middle East AI Medicine Software, by Application USD Million (2016-2021)
  • Table 100. Middle East AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 101. Middle East AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 102. Middle East AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 103. Africa AI Medicine Software, by Application USD Million (2016-2021)
  • Table 104. Africa AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 105. Africa AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 106. Africa AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 107. North America AI Medicine Software, by Country USD Million (2016-2021)
  • Table 108. North America AI Medicine Software, by Application USD Million (2016-2021)
  • Table 109. North America AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 110. North America AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 111. North America AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 112. United States AI Medicine Software, by Application USD Million (2016-2021)
  • Table 113. United States AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 114. United States AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 115. United States AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 116. Canada AI Medicine Software, by Application USD Million (2016-2021)
  • Table 117. Canada AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 118. Canada AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 119. Canada AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 120. Mexico AI Medicine Software, by Application USD Million (2016-2021)
  • Table 121. Mexico AI Medicine Software, by Enterprise Size USD Million (2016-2021)
  • Table 122. Mexico AI Medicine Software, by Deployment USD Million (2016-2021)
  • Table 123. Mexico AI Medicine Software, by End-user USD Million (2016-2021)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. AI Medicine Software: by Application(USD Million)
  • Table 142. AI Medicine Software Diagnosis Processes , by Region USD Million (2022-2027)
  • Table 143. AI Medicine Software Treatment Protocol Development , by Region USD Million (2022-2027)
  • Table 144. AI Medicine Software Drug Development , by Region USD Million (2022-2027)
  • Table 145. AI Medicine Software Personalized Medicine , by Region USD Million (2022-2027)
  • Table 146. AI Medicine Software Patient Monitoring & Care , by Region USD Million (2022-2027)
  • Table 147. AI Medicine Software: by Enterprise Size(USD Million)
  • Table 148. AI Medicine Software Small and Medium Enterprises , by Region USD Million (2022-2027)
  • Table 149. AI Medicine Software Large Enterprises , by Region USD Million (2022-2027)
  • Table 150. AI Medicine Software: by Deployment(USD Million)
  • Table 151. AI Medicine Software Cloud , by Region USD Million (2022-2027)
  • Table 152. AI Medicine Software On-Premises , by Region USD Million (2022-2027)
  • Table 153. AI Medicine Software: by End-user(USD Million)
  • Table 154. AI Medicine Software Hospitals , by Region USD Million (2022-2027)
  • Table 155. AI Medicine Software Diagnostic Centers , by Region USD Million (2022-2027)
  • Table 156. AI Medicine Software Laboratories , by Region USD Million (2022-2027)
  • Table 157. AI Medicine Software Research Institutions , by Region USD Million (2022-2027)
  • Table 158. AI Medicine Software Others , by Region USD Million (2022-2027)
  • Table 159. South America AI Medicine Software, by Country USD Million (2022-2027)
  • Table 160. South America AI Medicine Software, by Application USD Million (2022-2027)
  • Table 161. South America AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 162. South America AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 163. South America AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 164. Brazil AI Medicine Software, by Application USD Million (2022-2027)
  • Table 165. Brazil AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 166. Brazil AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 167. Brazil AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 168. Argentina AI Medicine Software, by Application USD Million (2022-2027)
  • Table 169. Argentina AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 170. Argentina AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 171. Argentina AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 172. Rest of South America AI Medicine Software, by Application USD Million (2022-2027)
  • Table 173. Rest of South America AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 174. Rest of South America AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 175. Rest of South America AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 176. Asia Pacific AI Medicine Software, by Country USD Million (2022-2027)
  • Table 177. Asia Pacific AI Medicine Software, by Application USD Million (2022-2027)
  • Table 178. Asia Pacific AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 179. Asia Pacific AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 180. Asia Pacific AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 181. China AI Medicine Software, by Application USD Million (2022-2027)
  • Table 182. China AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 183. China AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 184. China AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 185. Japan AI Medicine Software, by Application USD Million (2022-2027)
  • Table 186. Japan AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 187. Japan AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 188. Japan AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 189. India AI Medicine Software, by Application USD Million (2022-2027)
  • Table 190. India AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 191. India AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 192. India AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 193. South Korea AI Medicine Software, by Application USD Million (2022-2027)
  • Table 194. South Korea AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 195. South Korea AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 196. South Korea AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 197. Australia AI Medicine Software, by Application USD Million (2022-2027)
  • Table 198. Australia AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 199. Australia AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 200. Australia AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 201. Rest of Asia-Pacific AI Medicine Software, by Application USD Million (2022-2027)
  • Table 202. Rest of Asia-Pacific AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 203. Rest of Asia-Pacific AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 204. Rest of Asia-Pacific AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 205. Europe AI Medicine Software, by Country USD Million (2022-2027)
  • Table 206. Europe AI Medicine Software, by Application USD Million (2022-2027)
  • Table 207. Europe AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 208. Europe AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 209. Europe AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 210. Germany AI Medicine Software, by Application USD Million (2022-2027)
  • Table 211. Germany AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 212. Germany AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 213. Germany AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 214. France AI Medicine Software, by Application USD Million (2022-2027)
  • Table 215. France AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 216. France AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 217. France AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 218. Italy AI Medicine Software, by Application USD Million (2022-2027)
  • Table 219. Italy AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 220. Italy AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 221. Italy AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 222. United Kingdom AI Medicine Software, by Application USD Million (2022-2027)
  • Table 223. United Kingdom AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 224. United Kingdom AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 225. United Kingdom AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 226. Netherlands AI Medicine Software, by Application USD Million (2022-2027)
  • Table 227. Netherlands AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 228. Netherlands AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 229. Netherlands AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 230. Rest of Europe AI Medicine Software, by Application USD Million (2022-2027)
  • Table 231. Rest of Europe AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 232. Rest of Europe AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 233. Rest of Europe AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 234. MEA AI Medicine Software, by Country USD Million (2022-2027)
  • Table 235. MEA AI Medicine Software, by Application USD Million (2022-2027)
  • Table 236. MEA AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 237. MEA AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 238. MEA AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 239. Middle East AI Medicine Software, by Application USD Million (2022-2027)
  • Table 240. Middle East AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 241. Middle East AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 242. Middle East AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 243. Africa AI Medicine Software, by Application USD Million (2022-2027)
  • Table 244. Africa AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 245. Africa AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 246. Africa AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 247. North America AI Medicine Software, by Country USD Million (2022-2027)
  • Table 248. North America AI Medicine Software, by Application USD Million (2022-2027)
  • Table 249. North America AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 250. North America AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 251. North America AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 252. United States AI Medicine Software, by Application USD Million (2022-2027)
  • Table 253. United States AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 254. United States AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 255. United States AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 256. Canada AI Medicine Software, by Application USD Million (2022-2027)
  • Table 257. Canada AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 258. Canada AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 259. Canada AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 260. Mexico AI Medicine Software, by Application USD Million (2022-2027)
  • Table 261. Mexico AI Medicine Software, by Enterprise Size USD Million (2022-2027)
  • Table 262. Mexico AI Medicine Software, by Deployment USD Million (2022-2027)
  • Table 263. Mexico AI Medicine Software, by End-user USD Million (2022-2027)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global AI Medicine Software: by Application USD Million (2016-2021)
  • Figure 5. Global AI Medicine Software: by Enterprise Size USD Million (2016-2021)
  • Figure 6. Global AI Medicine Software: by Deployment USD Million (2016-2021)
  • Figure 7. Global AI Medicine Software: by End-user USD Million (2016-2021)
  • Figure 8. South America AI Medicine Software Share (%), by Country
  • Figure 9. Asia Pacific AI Medicine Software Share (%), by Country
  • Figure 10. Europe AI Medicine Software Share (%), by Country
  • Figure 11. MEA AI Medicine Software Share (%), by Country
  • Figure 12. North America AI Medicine Software Share (%), by Country
  • Figure 13. Global AI Medicine Software share by Players 2021 (%)
  • Figure 14. Global AI Medicine Software share by Players (Top 3) 2021(%)
  • Figure 15. Global AI Medicine Software share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 18. IBM (United States) Revenue: by Geography 2021
  • Figure 19. Oncora Medical (United States) Revenue, Net Income and Gross profit
  • Figure 20. Oncora Medical (United States) Revenue: by Geography 2021
  • Figure 21. Babylon Health (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Babylon Health (United Kingdom) Revenue: by Geography 2021
  • Figure 23. Arterys (United States) Revenue, Net Income and Gross profit
  • Figure 24. Arterys (United States) Revenue: by Geography 2021
  • Figure 25. CloudMedx (United States) Revenue, Net Income and Gross profit
  • Figure 26. CloudMedx (United States) Revenue: by Geography 2021
  • Figure 27. Corti (Denmark) Revenue, Net Income and Gross profit
  • Figure 28. Corti (Denmark) Revenue: by Geography 2021
  • Figure 29. Sophia Genetics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Sophia Genetics (Switzerland) Revenue: by Geography 2021
  • Figure 31. Enlitic (United States) Revenue, Net Income and Gross profit
  • Figure 32. Enlitic (United States) Revenue: by Geography 2021
  • Figure 33. Caption Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. Caption Health (United States) Revenue: by Geography 2021
  • Figure 35. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 36. 3M (United States) Revenue: by Geography 2021
  • Figure 37. OSP (United States) Revenue, Net Income and Gross profit
  • Figure 38. OSP (United States) Revenue: by Geography 2021
  • Figure 39. Microsoft Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Microsoft Corporation (United States) Revenue: by Geography 2021
  • Figure 41. GNS Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 42. GNS Healthcare (United States) Revenue: by Geography 2021
  • Figure 43. Carta Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 44. Carta Healthcare (United States) Revenue: by Geography 2021
  • Figure 45. Ada Health (Germany) Revenue, Net Income and Gross profit
  • Figure 46. Ada Health (Germany) Revenue: by Geography 2021
  • Figure 47. Sirona Medical (United States) Revenue, Net Income and Gross profit
  • Figure 48. Sirona Medical (United States) Revenue: by Geography 2021
  • Figure 49. Promaton (Netherlands) Revenue, Net Income and Gross profit
  • Figure 50. Promaton (Netherlands) Revenue: by Geography 2021
  • Figure 51. Global AI Medicine Software: by Application USD Million (2022-2027)
  • Figure 52. Global AI Medicine Software: by Enterprise Size USD Million (2022-2027)
  • Figure 53. Global AI Medicine Software: by Deployment USD Million (2022-2027)
  • Figure 54. Global AI Medicine Software: by End-user USD Million (2022-2027)
  • Figure 55. South America AI Medicine Software Share (%), by Country
  • Figure 56. Asia Pacific AI Medicine Software Share (%), by Country
  • Figure 57. Europe AI Medicine Software Share (%), by Country
  • Figure 58. MEA AI Medicine Software Share (%), by Country
  • Figure 59. North America AI Medicine Software Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • IBM (United States)
  • Oncora Medical (United States)
  • Babylon Health (United Kingdom)
  • Arterys (United States)
  • CloudMedx (United States)
  • Corti (Denmark)
  • Sophia Genetics (Switzerland)
  • Enlitic (United States)
  • Caption Health (United States)
  • 3M (United States)
  • OSP (United States)
  • Microsoft Corporation (United States)
  • GNS Healthcare (United States)
  • Carta Healthcare (United States)
  • Ada Health (Germany)
  • Sirona Medical (United States)
  • Promaton (Netherlands)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation